Compound ID | 1269
Cycloberberine analogue 5b
Class: Small molecule antibacterial agent
| Agent Type: | Semisynthetic; Small molecule; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against methicillin-resistant and -susceptible Staphylococcus aureus |
| Description: | A 13-substituted cycloberberine derivative |
| Institute where first reported: | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing, China |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://doi.org/10.1016/j.ejmech.2018.08.050 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.